American Cancer Society. What’s non-small cell cancer of the lung? http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-what-is-non-small-cell-lung-cancer. Utilized April 20, 2016.
Asmis TR, Ding K, Seymour L, et al. Age and comorbidity as independent prognostic factors in treating non-small-cell cancer of the lung: overview of National Cancer Institute of Canada Numerous Studies Group trials. J Clin Oncol. 200826(1):54-59.
Pao W, Girard N. Motorist mutations in non-small-cell cancer of the lung. Lancet Oncol. 201112(2):175-180.
Perez-Moreno P, Brambilla E, Thomas R, Soria JC. Squamous cell carcinoma from the lung: molecular subtypes and therapeutic possibilities. Clin Cancer Res. 201218(9):2443-2451.
Zhao W, Choi Y, Song J, Zhu Y, et al. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are extremely rare. Cancer Of The Lung. 201694:22-27.
Davies KD, Le AT, Theodoro MF, et al. Identifying and targeting ROS1 gene fusions in non-small cell cancer of the lung. Clin Cancer Res. 2012:18(17):4570–4579.
From Ferlay J, Soerjomataran I, Ervik M, et al. GLOBOCAN 2012 v1.. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France. Worldwide Agency for Research on Cancer 2013. Offered by http://globocan.iarc.fr. Utilized April 20, 2016.
SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/statfacts/html/lungb.html. Utilized April 20, 2016.
SEER Cancer Statistics Factsheets: Colon and Rectum Cancer. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/statfacts/html/colorect.html. Utilized April 20, 2016.
SEER Cancer Statistics Factsheets: Cancer Of The Prostate. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/statfacts/html/prost.html. Utilized April 20, 2016.
SEER Cancer Statistics Factsheets: Cancer Of The Breast. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/statfacts/html/breast.html. Utilized April 20, 2016.
The EUROCARE-4 database on cancer survival in Europe. http://www.eurocare.it/Results/tabid/79/Default.aspx. Utilized December 4, 2014.
Reck M, Popat S, Reinmuth N, et al. Metastatic non-small-cell cancer of the lung (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 201425(suppl 3):iii27-iii39.
Hoang T, Dahlberg SE, Schiller JH, Manley DH. Does histology predict survival of advanced non-small cell cancer of the lung patients given platin-based chemotherapy? An research into the Eastern Cooperative Oncology Group Study E1594. Cancer Of The Lung. 201381(1):47-52.
Ellis LM, Bernstein DS, Voest EE, et al. American Society of Clinical Oncology perspective: raising the bar for numerous studies by defining clinically significant outcomes. J Clin Oncol. 201432(12):1277-1280.
Nichols L, Saunders R, Knollmann FD. Reasons for dying of patients with cancer of the lung. Arch Pathol Lab Mediterranean. 2012136(12):1552-1557.
Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell cancer of the lung within the U . s . States: epidemiology, pathology and patterns of care. Cancer Of The Lung. 200757(3):253-260.
Lung cancer types | Respiratory system diseases | NCLEX-RN | Khan Academy